CB
SRPT icon

Commerce Bank’s Sarepta Therapeutics SRPT Stock Holding History

Commerce Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
25,623
+1,129
+5% +$21.4K ﹤0.01% 997
2026
Q1 		$533K Buy
24,494
+161
+0.7% +$3.12K ﹤0.01% 914
2025
Q4 		$524K Buy
24,333
+1,412
+6% +$29.8K ﹤0.01% 861
2025
Q3 		$442K Buy
+22,921
New +$409K ﹤0.01% 921
2025
Q1 		– Sell
-2,041
Closed -$248K – 1198
2024
Q4 		$248K Buy
2,041
+25
+1% +$3.06K ﹤0.01% 1085
2024
Q3 		$252K Buy
2,016
+274
+16% +$37.9K ﹤0.01% 1112
2024
Q2 		$275K Buy
1,742
+57
+3% +$7.32K ﹤0.01% 1052
2024
Q1 		$218K Buy
+1,685
New +$206K ﹤0.01% 1124
2023
Q4 		– Sell
-1,943
Closed -$236K – 1202
2023
Q3 		$236K Buy
1,943
+143
+8% +$16.2K ﹤0.01% 1040
2023
Q2 		$206K Buy
1,800
+236
+15% +$30.4K ﹤0.01% 1084
2023
Q1 		$216K Buy
+1,564
New +$203K ﹤0.01% 1079
2022
Q2 		– Sell
-2,693
Closed -$210K – 1202
2022
Q1 		$210K Buy
2,693
+361
+15% +$27.6K ﹤0.01% 1124
2021
Q4 		$210K Buy
+2,332
New +$199K ﹤0.01% 1134
2021
Q3 		– Sell
-3,499
Closed -$272K – 1183
2021
Q2 		$272K Buy
3,499
+242
+7% +$18.3K ﹤0.01% 1037
2021
Q1 		$243K Buy
3,257
+230
+8% +$21.2K ﹤0.01% 1045
2020
Q4 		$516K Sell
3,027
-164
-5% -$24.3K ﹤0.01% 762
2020
Q3 		$448K Buy
3,191
+7
+0.2% +$1.06K ﹤0.01% 719
2020
Q2 		$511K Sell
3,184
-48
-1% -$6.53K 0.01% 660
2020
Q1 		$316K Buy
+3,232
New +$369K ﹤0.01% 744

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Commerce Bank's SRPT Position: Q2 2026 in Review

Commerce Bank increased its Sarepta Therapeutics (SRPT) stake by 4.6% in Q2 2026, buying an estimated $21.4K and bringing the position to 25,623 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Commerce Bank first reported a position in SRPT in Q1 2020 and has held it in 19 quarters since. The position peaked at $533K in Q1 2026. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Commerce Bank held 25,623 shares of Sarepta Therapeutics worth $460K as of Q2 2026.
  • Commerce Bank bought 1,129 Sarepta Therapeutics shares in Q2 2026, an estimated $21.4K.
  • Sarepta Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #997 holding.
  • Commerce Bank first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 19 quarters since.
  • Commerce Bank's Sarepta Therapeutics position peaked at $533K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.